Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CTAna Jiménez Ubieto, Santiago Barrio, Inmaculada Rapado et al.|Leukemia|2023Cited by 40
CNL and aCML should be considered as a single entity based on molecular profiles and outcomesGonzalo Carreño‐Tarragona, Nicholas C.P. Cross, Alberto Álvarez‐Larrán et al.|Blood Advances|2023Cited by 32
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNARicardo Sánchez, Joaquín Martínez‐López, Sara Dorado et al.|Scientific Reports|2022Cited by 12
Minimal Residual Disease Monitoring from Liquid Biopsy By Next Generation Sequencing in Follicular Lymphoma PatientsAna Isabel Jiminez Ubieto, Santiago Barrio, Yanira Heredia et al.|Blood|2020Cited by 4
Potential Utility of Circulating Tumor DNA Monitoring in Primary Mediastinal B-Cell Lymphoma Treated with R-DA-EPOCHAna Jiménez Ubieto, Santiago Barrio, María Poza et al.|Blood|2021Cited by 4